You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,940,115

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 10,940,115 protect, and when does it expire?

Patent 10,940,115 protects FERRIPROX and is included in one NDA.

This patent has twenty-one patent family members in seventeen countries.

Summary for Patent: 10,940,115

Patent landscape, scope, and claims:

Title:	Delayed release deferiprone tablets and methods of using the same
Abstract:	The invention is directed to pharmaceutical compositions such as tablets that exhibit delayed release properties when administered as either whole or half tablets. The invention is also directed to delayed release tablets comprising deferiprone for oral administration, for which twice daily administration is bioequivalent to the same daily dose of an immediate release tablet administered thrice daily. The invention is also directed to methods of making and using the same.
Inventor(s):	Sherman; Bernard Charles (Toronto, CA), Spino; Michael (Pickering, CA)
Assignee:	Chiesi Farmaceutici S.p.A. (Parma, IT)
Application Number:	15/930,373
Patent Claim Types: see list of patent claims	Use; Composition; Dosage form;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 10,940,115

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Chiesi	FERRIPROX	deferiprone	TABLET;ORAL	212269-001	May 19, 2020		RX	Yes	Yes	10,940,115	⤷ Subscribe	Y			METHOD OF TREATING TRANSFUSIONAL IRON OVERLOAD	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 10,940,115

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2018357350	⤷ Subscribe
Brazil	112020008128	⤷ Subscribe
Canada	3077514	⤷ Subscribe
Canada	3172668	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.